CARsgen Therapeutics Holdings Limited (2171.HK)

Healthcare | Biotechnology
Income Statement (Quarterly) 2026-04-09 2025-06-30 2025-03-31 2024-12-31
Revenue 0 0 0 0
Cost of Revenue 0 0 0 0
Gross Profit 0 0 0 0
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 0 0 0 0
Operating Expenses 0 0 0 0
Operating Income 0 0 0 0
Interest Expense 0 0 0 0
Income Before Tax 0 0 0 0
Income Tax Expense 0 0 0 0
Net Income 0 0 0 0
Per Share
EPS -0.14 -0.14 -0.07 0.00
EPS Diluted 0.00 0.00 0.00 0.00
Income Statement (Annual) 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue 39,425,000 0 0 25,813,000 0
Cost of Revenue 24,678,000 0 0 0 0
Gross Profit 14,747,000 0 0 25,813,000 0
Operating Expenses
R&D Expenses 0 0 0 0 0
SG&A Expenses 52,024,000 133,312,000 46,822,000 65,816,000 54,800,000
Operating Expenses 822,938,000 767,649,000 802,281,000 611,802,000 348,668,000
Operating Income -808,191,000 -767,649,000 -881,297,000 -573,905,000 -348,668,000
Interest Expense 5,713,000 0 15,521,000 10,869,000 13,480,000
Income Before Tax -797,786,000 -747,387,000 -890,952,000 -4,736,778,000 -1,064,049,000
Income Tax Expense 346,000 407,000 1,295,000 7,645,000 0
Net Income -798,132,000 -747,794,000 -892,247,000 -4,744,423,000 -1,064,049,000
Per Share
EPS -1.44 -1.34 -1.62 -8.36 -1.88
EPS Diluted 0.00 0.00 0.00 0.00 0.00
Balance Sheet (Quarterly) 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Assets
Cash and Cash Equivalents 1,479,058,000 1,849,752,000 2,268,036,000 691,284,000
Short Term Investments 0 1,128,000 6,309 2,315,654,000
Net Receivables 27,273,000 0 0 0
Inventory 6,926,000 683,000 0 0
Total Current Assets 1,530,275,000 1,873,088,000 2,300,639,000 3,070,853,000
Property Plant Equipment 123,949,000 361,390,000 436,863,000 384,766,000
Goodwill and Intangibles 2,943,000 8,660,000 21,106,000 26,919,000
Total Assets 1,673,034,000 2,257,214,000 2,762,819,000 3,505,635,000
Liabilities
Account Payables 0 0 0 0
Short Term Debt 33,728,000 14,752,000 21,984,000 233,358,000
Total Current Liabilities 254,007,000 196,217,000 171,004,000 389,172,000
Long Term Debt 132,694,000 70,468,000 97,461,000 104,687,000
Total Liabilities 616,327,000 455,514,000 289,645,000 508,975,000
Shareholders Equity
Retained Earnings 0 -8,189,829,000 -7,442,035,000 0
Total Shareholders Equity 1,056,707,000 1,801,700,000 2,473,174,000 2,996,660,000
Balance Sheet (Annual) 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Assets
Cash and Cash Equivalents 1,479,058,000 1,849,752,000 2,268,036,000 691,284,000 1,042,969,000
Short Term Investments 0 1,128,000 6,309 2,315,654,000 0
Net Receivables 27,273,000 0 0 0 0
Inventory 6,926,000 683,000 0 0 0
Total Current Assets 1,530,275,000 1,873,088,000 2,300,639,000 3,070,853,000 1,055,795,000
Property Plant Equipment 123,949,000 361,390,000 436,863,000 384,766,000 158,255,000
Goodwill and Intangibles 2,943,000 8,660,000 21,106,000 26,919,000 30,463,000
Total Assets 1,673,034,000 2,257,214,000 2,762,819,000 3,505,635,000 1,253,851,000
Liabilities
Account Payables 0 0 0 0 0
Short Term Debt 33,728,000 14,752,000 21,984,000 233,358,000 74,261,000
Total Current Liabilities 254,007,000 196,217,000 171,004,000 389,172,000 145,231,000
Long Term Debt 132,694,000 70,468,000 97,461,000 104,687,000 25,997,000
Total Liabilities 616,327,000 455,514,000 289,645,000 508,975,000 2,929,979,000
Shareholders Equity
Retained Earnings 0 -8,189,829,000 -7,442,035,000 0 -1,822,803,000
Total Shareholders Equity 1,056,707,000 1,801,700,000 2,473,174,000 2,996,660,000 -1,676,128,000
Cash Flow Statement (Quarterly) 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Operating Activities
Net Income -798,132,000 -747,387,000 -890,952,000 -4,744,423,000
Depreciation & Amortization 79,555,000 87,395,000 81,533,000 52,446,000
Stock Based Compensation 9,089,000 14,458,000 43,995,000 13,504,000
Change in Working Capital 0 211,375,000 43,482,000 13,379,000
Operating Cash Flow -409,690,000 -454,935,000 -643,048,000 -512,322,000
Investing Activities
Capital Expenditure 0 -9,549,000 -138,614,000 -178,453,000
Investments 0 -8,835,000 -138,614,000 -175,841,000
Investing Cash Flow 12,522,000 39,251,000 2,386,990,000 -2,471,321,000
Financing Activities
Debt Repayment 0 -24,072,000 -327,748,000 -146,865,000
Common Stock Issued/Repurchased -50,272,000 6,610,000 10,505,000 2,576,082,000
Dividends Paid 0 0 0 0
Financing Cash Flow 18,457,000 -22,142,000 -236,514,000 2,674,032,000
Summary
Free Cash Flow -429,264,000 -464,484,000 -781,662,000 -690,775,000
Net Change in Cash -370,694,000 -418,284,000 1,576,752,000 -351,685,000
Cash Flow Statement (Annual) 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Operating Activities
Net Income -798,132,000 -747,387,000 -890,952,000 -4,744,423,000 -1,064,049,000
Depreciation & Amortization 79,555,000 87,395,000 81,533,000 52,446,000 40,109,000
Stock Based Compensation 9,089,000 14,458,000 43,995,000 13,504,000 1,714,000
Change in Working Capital 0 211,375,000 43,482,000 13,379,000 13,451,000
Operating Cash Flow -409,690,000 -454,935,000 -643,048,000 -512,322,000 -295,150,000
Investing Activities
Capital Expenditure 0 -9,549,000 -138,614,000 -178,453,000 -18,735,000
Investments 0 -8,835,000 -138,614,000 -175,841,000 -17,727,000
Investing Cash Flow 12,522,000 39,251,000 2,386,990,000 -2,471,321,000 -6,897,000
Financing Activities
Debt Repayment 0 -24,072,000 -327,748,000 -146,865,000 -157,777,000
Common Stock Issued/Repurchased -50,272,000 6,610,000 10,505,000 2,576,082,000 0
Dividends Paid 0 0 0 0 0
Financing Cash Flow 18,457,000 -22,142,000 -236,514,000 2,674,032,000 1,302,473,000
Summary
Free Cash Flow -429,264,000 -464,484,000 -781,662,000 -690,775,000 -313,885,000
Net Change in Cash -370,694,000 -418,284,000 1,576,752,000 -351,685,000 946,493,000